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ORRESPONDENCE
ew perspectives for the use of
igh-ﬂow nasal oxygen
in  hospital  wards  and  help  decrease  admissions  to  intensive
care  units.2,3t
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igh-ﬂow  nasal  cannula  (HFNC)  oxygen  therapy  is  an  innova-
ive  modality  for  early  treatment  of  adults  with  respiratory
ailure  and  has  physiological  advantages  compared  to  other
tandard  oxygen  therapies.
We  read  carefully  the  article  by  Demelo-Rodriguez  et  al.1
nd  congratulate  the  authors  on  their  study.  There  are,  how-
ver,  some  points  to  be  taken  into  consideration.
This  study  includes  patients  with  different  types  of  acute
espiratory  failure  (ARF)  which  makes  it  difﬁcult  to  establish
hich  patients  beneﬁt  most  from  HFNC.  It  would,  therefore,
e  useful  to  have  larger  and  more  randomized  controlled
rials,  with  speciﬁc  disorders  such  as  chronic  obstructive
ulmonary  disease  (COPD)  or  idiopathic  pulmonary  ﬁbrosis
IPF),  to  substantiate  indications  and  criteria  for  the  man-
gement  of  HFNC.2--4
In  IPF,  the  most  common  interstitial  lung  disease  and
ith  high  mortality,  in  which  prognosis  is  extremely  poor
fter  mechanical  ventilation,  HFNC  appears  to  be  an  alter-
ative  modality  for  treating  patients  with  hypoxemia  who
o  not  require  immediate  intubation,  providing  better  oxy-
enation,  dyspnea  relief  and  comfort.3,5
The  use  of  HFNC  has  also  been  described  in  stable
ypercapnic  COPD  patients  with  interesting  results,  such  as
ncreased  tidal  volume  and  reduction  of  respiratory  rate,
inute  volumes  and  capillary  pCO2,  enabling  it  to  be  an
lternative  to  noninvasive  ventilation.5 The  dead  space
ash-out  of  the  upper  respiratory  airway  and  the  posi-
ive  end  expiratory  pressure  effect  may  contribute  to  these
mportant  effects  of  HFNC.5
HFNC  is  easy-to-use  and  is  well  tolerated,  as  described
n  this  study,  which  was  carried  out  in  an  Intermediate
are  Unit.  In  the  future  it  may  be  used  more  frequentlyttp://dx.doi.org/10.1016/j.rppnen.2016.06.008
173-5115/© 2016 Sociedade Portuguesa de Pneumologia. Published by 
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)In  short,  HFNC  is  a  useful  and  exciting  modality  for  the
reatment  of  patients  with  respiratory  failure  and  its  use  is
rowing  worldwide.4
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